#1 Clinical Trials Search in Europe

Dronedarone

This article examines the use of dronedarone, a medication used to treat atrial fibrillation (AF), in various clinical trials. Dronedarone has been studied for its effects on preventing AF recurrence, reducing cardiovascular events, and improving heart function in patients with AF. The trials explored different aspects of dronedarone’s efficacy and safety compared to placebo or standard treatments.

Table of Contents

What is Dronedarone?

Dronedarone is a medication used to treat certain heart rhythm problems. It’s known by the brand name Multaq® and is also referred to as SR33589 in some medical literature[5]. Dronedarone is similar to another heart medication called amiodarone, but it has been designed to have fewer side effects[4].

Uses of Dronedarone

Dronedarone is primarily used to treat a condition called atrial fibrillation (AF). AF is a type of irregular heartbeat where the upper chambers of the heart (atria) beat chaotically and out of sync with the lower chambers[1]. This medication is used in different scenarios:

  • To prevent recurrence of AF in patients who have had their normal heart rhythm restored[1]
  • To control heart rate in patients with permanent AF[2]
  • To reduce the risk of hospitalization due to AF[3]
  • In some cases, to prevent recurrent shocks in patients with implantable cardioverter defibrillators (ICDs)[4]

How Dronedarone Works

Dronedarone works by affecting various electrical properties of the heart. It belongs to a class of medications called antiarrhythmic drugs. These drugs help to restore and maintain a normal heart rhythm. Dronedarone has properties that span all four Vaughan-Williams classes of antiarrhythmic drugs, which means it affects different aspects of the heart’s electrical system[3]. This broad action helps to:

  • Slow down the heart rate during AF episodes
  • Reduce the likelihood of AF recurring
  • Help maintain a normal heart rhythm once it’s restored

Dosage and Administration

Dronedarone is typically prescribed as a 400 mg tablet to be taken twice daily. It’s important to take this medication with food, usually during breakfast and dinner[2][5]. Your doctor will provide specific instructions on how to take the medication, which may vary depending on your individual situation and other medications you’re taking.

Effectiveness of Dronedarone

Several studies have shown that dronedarone can be effective in managing AF:

  • It can help reduce the frequency of AF episodes[1]
  • It may slow down the heart rate during AF episodes[2]
  • It has been shown to reduce hospitalizations related to AF[3]
  • Some studies suggest it might help prevent AF recurrence after procedures like cardioversion (restoring normal heart rhythm) or ablation (a procedure to treat certain heart rhythm problems)[6][7]

Side Effects and Safety

Like all medications, dronedarone can cause side effects. Some potential side effects that have been observed in clinical trials include:

  • Slow heart rate (bradycardia)[1]
  • Fast heart rate (tachycardia)[1]
  • Liver problems[3]
  • Heart failure[3]
  • Skin disorders[5]

It’s important to note that dronedarone is generally considered to have fewer side effects than some other antiarrhythmic drugs, particularly amiodarone[3]. However, your doctor will carefully consider your individual situation when prescribing this medication.

Ongoing Research

Researchers continue to study dronedarone to better understand its effects and potential uses. Some areas of ongoing research include:

  • Using dronedarone to prevent AF recurrence after ablation procedures[7]
  • Studying the effects of dronedarone on heart structure and function in patients with AF[8]
  • Investigating the optimal timing of starting dronedarone treatment in different scenarios[1][6]

These ongoing studies aim to provide more information about how to use dronedarone most effectively and safely in different patient groups.

Aspect Details
Main Use Treatment of atrial fibrillation (AF)
Dosage Typically 400 mg twice daily with meals
Primary Outcomes Studied AF recurrence, cardiovascular hospitalization, death from any cause
Secondary Outcomes Left atrial function, ventricular rate during AF, quality of life
Safety Profile Generally well-tolerated; rare serious side effects include liver problems
Comparison to Other Treatments Better safety profile than some antiarrhythmic drugs, especially regarding thyroid and neurologic effects
Patient Populations Studied in various AF types; not suitable for severe heart failure or permanent AF
Imaging Studies Effects on cardiac structure and fibrosis assessed using MRI in some trials

FAQ

  • What is dronedarone used for? Dronedarone is primarily used to treat atrial fibrillation, a common heart rhythm disorder. It helps to maintain normal heart rhythm and reduce the risk of cardiovascular hospitalization in patients with AF.
  • How does dronedarone compare to other treatments for AF? Clinical trials have shown that dronedarone can be effective in preventing AF recurrence and reducing cardiovascular events. It has a better safety profile than some other antiarrhythmic drugs, particularly regarding thyroid and neurologic side effects.
  • What are the main side effects of dronedarone? Common side effects of dronedarone may include gastrointestinal issues, fatigue, and skin reactions. More serious but rare side effects can include liver problems and worsening of heart failure in certain patients.
  • How is dronedarone typically administered? Dronedarone is usually taken as a 400 mg tablet twice daily with meals. The exact dosing and duration of treatment may vary based on the patient's condition and response to the medication.
  • Can dronedarone be used in all patients with atrial fibrillation? Dronedarone is not suitable for all AF patients. It should not be used in patients with severe heart failure or permanent AF. Your doctor will determine if dronedarone is appropriate based on your specific medical history and condition.

Ongoing Clinical Trials on Dronedarone

  • Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

    Recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Denmark Germany Hungary Norway Slovakia +1

Glossary

  • Atrial Fibrillation (AF): A common heart rhythm disorder characterized by irregular and often rapid heartbeat, which can increase the risk of stroke and other complications.
  • Cardioversion: A medical procedure used to restore normal heart rhythm in patients with arrhythmias like atrial fibrillation, often done using electrical shocks or medications.
  • Electrogram (EGM): A recording of the electrical activity of the heart, typically obtained from electrodes placed directly on or in the heart.
  • Left Atrial Volume Index (LAVi): A measurement of the size of the left atrium of the heart, adjusted for body size, which can be an indicator of heart health and function.
  • Ventricular Rate: The speed at which the heart's lower chambers (ventricles) beat, often measured in beats per minute.
  • Antiarrhythmic Drug: A medication used to treat or prevent abnormal heart rhythms, such as atrial fibrillation.
  • Cardiac Remodeling: Changes in the size, shape, and function of the heart in response to stress or injury, which can occur in conditions like atrial fibrillation.
  • Ejection Fraction: A measurement of how well the heart pumps blood, expressed as a percentage of blood pumped out with each heartbeat.
  • Fibrosis: The formation of excess fibrous connective tissue in an organ or tissue, which can affect heart function in conditions like atrial fibrillation.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.

References

  1. https://clinicaltrials.gov/study/NCT01140581
  2. https://clinicaltrials.gov/study/NCT01213368
  3. https://clinicaltrials.gov/study/NCT05130268
  4. https://clinicaltrials.gov/study/NCT01430806
  5. https://clinicaltrials.gov/study/NCT01199081
  6. https://clinicaltrials.gov/study/NCT01026090
  7. https://clinicaltrials.gov/study/NCT05655468
  8. https://clinicaltrials.gov/study/NCT01198873